✓ No loaded language, vague sourcing, or framing detected.
The FDA has removed black-box warnings from three estrogen patches for menopause treatment, citing limited transparency in the decision-making process. This follows a similar removal of warnings from six treatments earlier this year.
Our neutral summary
The FDA has removed black-box warnings from three estrogen patches for menopause treatment, citing limited transparency in the decision-making process. This follows a similar removal of warnings from six treatments earlier this year.
The reporting belongs to Guardian — US; we don't reproduce it.
No note attached
on this article.
FDA again bypasses advisers to remove black-box warnings from menopause treatments
FDA Removes Black-Box Warnings from Additional Menopause Treatments